表1：经皮电针刺激和穴位按压缓解乳腺癌女性化疗相关不良反应的疗效与安全性：一项随机临床试验

数据集获取（Figshare）

• 源站标题：Table 1_Efficacy and safety of transcutaneous electrical acupoint stimulation and acupressure in alleviating chemotherapy-related adverse reactions in female patients with breast cancer: a randomized clinical trial.docx
• DOI：10.3389/fonc.2026.1788635.s005
• 发布日期：2026-04-15
• 文件数：1 个
• 文件总体积：35.85 KB
• 源站页面：https://frontiersin.figshare.com/articles/dataset/Table_1_Efficacy_and_safety_of_transcutaneous_electrical_acupoint_stimulation_and_acupressure_in_alleviating_chemotherapy-related_adverse_reactions_in_female_patients_with_breast_cancer_a_randomized_clinical_trial_docx/32017836

命令行下载

curl -L -o "Table 1_Efficacy and safety of transcutaneous electrical acupoint stimulation and acupressure in alleviating chemotherapy-related adverse reactions in.docx" "https://ndownloader.figshare.com/files/63740448"

文件清单

• Table 1_Efficacy and safety of transcutaneous electrical acupoint stimulation and acupressure in alleviating chemotherapy-related adverse reactions in.docx（35.85 KB）

文件总体积 35.85 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

BackgroundCommon adverse reactions to breast cancer chemotherapy (nausea, vomiting, sleep disorders, anxiety, depression) are often suboptimally managed. These symptoms undermine patients’s quality of life and reduce chemotherapy adherence. Two non-invasive Traditional Chinese Medicine (TCM) interventions—transcutaneous electrical acupoint stimulation (TEAS) and acupressure have demonstrated efficacy in alleviating such discomforts, data on their effectiveness and dynamic therapeutic characteristics throughout the full chemotherapy course remain insufficient.
Method198 breast cancer patients receiving chemotherapy were subjected to simple randomization using R4.4.2, and randomly assigned to the control group, TEAS group, and acupressure group for a longitudinal follow-up over four chemotherapy cycles. Generalized estimating equations (GEE) were used to analyze intervention effects and post-hoc multiple comparisons, supplemented by intention-to-treat (ITT) analysis and per-protocol set (PPS) analysis.
ResultsMain time effect: With the progression of chemotherapy cycles, the risk of delayed chemotherapy-induced nausea and vomiting (delayed CINV) significantly increased; patients’ anxiety levels were higher in the early stage of chemotherapy cycles and showed a downward trend after the 3rd cycle. Main intervention effect: TEAS significantly improved patients’ quality of life(QOL), while acupressure primarily alleviated psychological symptoms such as anxiety and depression. Interaction effect: The therapeutic effect of TEAS was cumulative, exerting more pronounced benefits in reducing the risk of delayed CINV, improving sleep quality, and relieving delayed nausea during the mid-to-late stages of chemotherapy (cycles 3-4); acupressure achieved optimal anxiety relief in the early stage (cycle 1) and progressively alleviated delayed nausea and enhanced QOL throughout the treatment course.
ConclusionTEAS and acupressure exhibit dynamic and distinct effects in mitigating adverse reactions in breast cancer patients undergoing chemotherapy. TEAS is more suitable for the comprehensive improvement of physical symptoms and QOL during the mid-to-late stages of chemotherapy, wh

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fonc.2026.1788635.s005（source: https://frontiersin.figshare.com/articles/dataset/Table_1_Efficacy_and_safety_of_transcutaneous_electrical_acupoint_stimulation_and_acupressure_in_alleviating_chemotherapy-related_adverse_reactions_in_female_patients_with_breast_cancer_a_randomized_clinical_trial_docx/32017836）。